Cargando…
A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer Patients
SIMPLE SUMMARY: In this study, Sel-Cap(TM), a next-generation sequencing (NGS)-based genotyping platform, showed high sensitivity for detection of epidermal growth factor receptor (EGFR) gene mutations in plasma samples collected from 185 patients with non-small cell lung cancer (NSCLC). In the earl...
Autores principales: | Shin, Jung-Young, Kim, Jeong-Oh, Lee, Mi-Ran, Kim, Seo Ree, Beck, Kyongmin Sarah, Kang, Jin Hyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760633/ https://www.ncbi.nlm.nih.gov/pubmed/33266057 http://dx.doi.org/10.3390/cancers12123579 |
Ejemplares similares
-
Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer
por: Kim, Jeong-Oh, et al.
Publicado: (2020) -
Genotyping Influenza Virus by Next-Generation Deep Sequencing in Clinical Specimens
por: Seong, Moon-Woo, et al.
Publicado: (2016) -
Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma
por: Kim, Hye Sook, et al.
Publicado: (2013) -
Diagnosis and Genotyping of Coxiella burnetii Endocarditis in a Patient with Prosthetic Pulmonary Valve Replacement Using Next-Generation Sequencing of Plasma Microbial Cell-Free DNA
por: Kondo, Maiko, et al.
Publicado: (2019) -
Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study
por: Park, Jung Ho, et al.
Publicado: (2022)